Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in France
3 of 10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Paris
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644 - No phaseTaking peopleFrench Registry for Monitoring Pregnancies for Multiple Sclerosis
- Where
- Amiens, Annecy, Avignon, Besançon, Bordeaux, Brive-la-Gaillarde, Bron, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon, Épinal, Garches, Gonesse, Grenoble, Le Chesnay, Lille, Limoges, Lyon, Marseille, Montpellier, Mornant, Nancy, Nice, Nîmes, Paris, Poissy, Poitiers, Pontoise, Rennes, Rouen, Saint-Denis, Saint-Herblain, Saint-Lô, Saint-Priest-en-Jarez, Strasbourg, Suresnes, Toulouse, Tours, Villeurbanne
- People
- 1,500 worldwide
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT03900221 - No phaseTaking peopleIntegrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
- Where
- Marseille
- Age
- 18 years to 90 years
- People
- 700
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT07202494